This inventor holds 1 USPTO granted patent. Top assignee: Origene Technologies, Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Innovations by Wei-Wu He in Nucleic Acid Screening
Introduction
Wei-Wu He is an accomplished inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid screening. His innovative work has led to the development of a patented technology that enhances the efficiency of cDNA library screening.
Latest Patents
Wei-Wu He holds a patent for "Rapid-screen cDNA library panels." This invention relates to arrays of nucleic acid and methods for screening these arrays to identify desired nucleotide sequences. In a preferred embodiment, a desired cDNA clone can be obtained in three or fewer rounds of PCR screening. The invention utilizes a master plate containing a population of cDNA distributed across multiple wells, which is screened for a desired clone by PCR. Once a master well containing the desired cDNA is identified, a second plate with a cDNA array from the master well can be screened using the same PCR primers. This method significantly reduces the number of candidates in a single PCR step, as the second plate contains about 50-fold to 100-fold fewer clones than the master plate.
Career Highlights
Wei-Wu He is currently associated with Origene Technologies, Inc., where he continues to advance his research and development efforts. His work has been instrumental in improving the methodologies used in genetic research and diagnostics.
Collaborations
Wei-Wu He collaborates with various professionals in his field, including his coworker Gilbert Jay. Their combined expertise contributes to the innovative projects at Origene Technologies, Inc.
Conclusion
Wei-Wu He is a notable inventor whose work in nucleic acid screening has the potential to transform genetic research methodologies. His patented technology exemplifies the importance of innovation in the life sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile